AU2011303467C1 - Method for separating target molecules or particles from fibrinogen-containing samples including blood components - Google Patents

Method for separating target molecules or particles from fibrinogen-containing samples including blood components Download PDF

Info

Publication number
AU2011303467C1
AU2011303467C1 AU2011303467A AU2011303467A AU2011303467C1 AU 2011303467 C1 AU2011303467 C1 AU 2011303467C1 AU 2011303467 A AU2011303467 A AU 2011303467A AU 2011303467 A AU2011303467 A AU 2011303467A AU 2011303467 C1 AU2011303467 C1 AU 2011303467C1
Authority
AU
Australia
Prior art keywords
sample
fibrinogen
fibrin
particles
thrombin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011303467A
Other languages
English (en)
Other versions
AU2011303467B2 (en
AU2011303467A1 (en
Inventor
Patrice Francois
Vladimir Lazarevic
Nicolas Mermod
Amar Rida
Jacques Schrenzel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiopharm International SA
Original Assignee
Debiopharm International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm International SA filed Critical Debiopharm International SA
Publication of AU2011303467A1 publication Critical patent/AU2011303467A1/en
Assigned to DEBIOPHARM INTERNATIONAL SA reassignment DEBIOPHARM INTERNATIONAL SA Request for Assignment Assignors: SPINOMIX S.A.
Publication of AU2011303467B2 publication Critical patent/AU2011303467B2/en
Priority to AU2016266066A priority Critical patent/AU2016266066B2/en
Application granted granted Critical
Publication of AU2011303467C1 publication Critical patent/AU2011303467C1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Sampling And Sample Adjustment (AREA)
AU2011303467A 2010-09-15 2011-09-15 Method for separating target molecules or particles from fibrinogen-containing samples including blood components Active AU2011303467C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016266066A AU2016266066B2 (en) 2010-09-15 2016-12-02 Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CH01478/10 2010-09-15
CH14782010 2010-09-15
CH20412010 2010-12-07
CH02041/10 2010-12-07
CH01207/11 2011-07-20
CH12072011 2011-07-20
PCT/IB2011/054035 WO2012035508A2 (en) 2010-09-15 2011-09-15 Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016266066A Division AU2016266066B2 (en) 2010-09-15 2016-12-02 Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Publications (3)

Publication Number Publication Date
AU2011303467A1 AU2011303467A1 (en) 2013-04-04
AU2011303467B2 AU2011303467B2 (en) 2016-09-15
AU2011303467C1 true AU2011303467C1 (en) 2017-03-09

Family

ID=45044632

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2011303467A Active AU2011303467C1 (en) 2010-09-15 2011-09-15 Method for separating target molecules or particles from fibrinogen-containing samples including blood components
AU2016266066A Active AU2016266066B2 (en) 2010-09-15 2016-12-02 Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2016266066A Active AU2016266066B2 (en) 2010-09-15 2016-12-02 Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Country Status (17)

Country Link
US (4) US9689881B2 (enExample)
EP (2) EP2616550B1 (enExample)
JP (1) JP5999776B2 (enExample)
KR (1) KR101948944B1 (enExample)
CN (2) CN107389932B (enExample)
AU (2) AU2011303467C1 (enExample)
CA (1) CA2811493C (enExample)
CY (1) CY1122166T1 (enExample)
DK (2) DK2616550T3 (enExample)
ES (2) ES2751660T3 (enExample)
HR (1) HRP20191785T1 (enExample)
HU (2) HUE028915T2 (enExample)
LT (1) LT3067431T (enExample)
PL (2) PL2616550T3 (enExample)
PT (1) PT3067431T (enExample)
SI (1) SI3067431T1 (enExample)
WO (1) WO2012035508A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9689881B2 (en) 2010-09-15 2017-06-27 Spinomix S.A. Method for separating target molecules or particles from fibrinogen-containing samples including blood components
CN103702674B (zh) 2011-06-27 2018-05-29 爱默蕾大学 血小板裂解物的组合物、用途和制备
EP2979093B1 (en) * 2013-03-29 2019-10-23 Siemens Healthcare Diagnostics Inc. Rare cell concentration
ES2740838T3 (es) * 2014-06-01 2020-02-06 Debiopharm Int Sa Dispositivo de recolección y procesamiento de muestras
US12397302B2 (en) 2015-11-30 2025-08-26 Dh Technologies Development Pte. Ltd. Electromagnetic assemblies for processing fluids
WO2017156375A1 (en) 2016-03-10 2017-09-14 Arthrex, Inc. Systems and methods for preparing a thrombin serum
WO2017156379A2 (en) 2016-03-10 2017-09-14 Arthrex, Inc. Systems and methods for preparing protein enhanced serums
KR20210052389A (ko) 2018-08-27 2021-05-10 리제너론 파마슈티칼스 인코포레이티드 다운스트림 정제에서의 라만 분광법의 사용
JP7298449B2 (ja) * 2019-11-14 2023-06-27 株式会社島津製作所 血液凝固分析装置、及び分注ノズルの洗浄方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068662A1 (en) * 1987-12-24 2003-04-10 Institut Pasteur Reagent for the detection of Staphylococcus aureus by agglutination
US6680195B1 (en) * 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
WO2007015782A1 (en) * 2005-07-29 2007-02-08 Ecole Polytechnique Federale De Lausanne Molecular variant fibrinogen fusion proteins
WO2010004004A1 (en) * 2008-07-09 2010-01-14 Profibrix Bv Recombinant fibrinogen

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1035260A (en) * 1974-08-12 1978-07-25 Baxter Travenol Laboratories Collection and processing tube
DE58902472D1 (de) * 1988-01-05 1992-11-26 Linhart Axel Verfahren und test-kit zur semiquantitativen bestimmung des kalziumgehaltes im blut.
DE3803463A1 (de) * 1988-02-05 1989-08-17 Linhart Axel Semiquantitativer kalzium-schnelltest
US5691160A (en) * 1992-08-14 1997-11-25 Biogen, Inc. Effects of actin filaments of fibrin clot structure and lysis
EP0587398B1 (en) * 1992-09-09 1998-01-14 Tokuyama Corporation Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof
JP3292760B2 (ja) * 1993-04-22 2002-06-17 テルモ株式会社 採血管およびその製造方法
US5670329A (en) * 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
WO1995015397A1 (en) 1993-12-03 1995-06-08 Dorn Gordon L Method for improving quantitative recovery of microorganisms fro m specimens containing blood components
DE19602673A1 (de) * 1996-01-25 1997-08-07 Pereg Gmbh Synthetische Testanschmutzung
US6121232A (en) * 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
JP2000262499A (ja) * 2000-01-01 2000-09-26 Terumo Corp 採血管
US6686204B2 (en) * 2001-08-27 2004-02-03 Becton, Dickinson & Company Collection device
WO2003028743A1 (en) * 2001-10-03 2003-04-10 Woolverton Christopher J Storage-stable fibrinogen solutions
JP4718833B2 (ja) * 2002-05-01 2011-07-06 シナプス ベスローテン フェンノートシャップ 複合生物媒体における、一時的なタンパク質分解活性の濃度を決定するための診断試験
EP1400589B1 (de) 2002-09-18 2006-08-09 SIRS-Lab GmbH Verfahren zum Nachweis prokaryontischer DNA
SI1654387T1 (sl) * 2003-08-15 2009-10-31 Univ South Florida Materiali in postopki za ujetje patogenov in odstranitev avrintrikarboksilne kisline iz vzorca
US20050065454A1 (en) * 2003-09-22 2005-03-24 Becton, Dickinson And Company Non-evacuated blood collection tube
US7399609B2 (en) * 2003-12-30 2008-07-15 3M Innovative Properties Company Staphylococcus detection
US8419722B2 (en) * 2004-10-29 2013-04-16 Spinal Restoration, Inc. Apparatus and method for injection of fibrin sealant in spinal applications
DE102005009479A1 (de) 2005-03-02 2006-09-07 Molzym Gmbh & Co. Kg Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden
US20080299587A1 (en) * 2007-05-03 2008-12-04 Dennis Durbin Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
CA2693565C (en) 2007-08-02 2015-05-26 Universite Laval Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids
JP5029217B2 (ja) * 2007-08-27 2012-09-19 東レ株式会社 シート状物の製造方法
CA2768485C (en) 2009-07-16 2018-12-04 Timothy Foster Treatment of staphylococci infections using recombinant fibrinogen binding protein clumping factor a
US9689881B2 (en) 2010-09-15 2017-06-27 Spinomix S.A. Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068662A1 (en) * 1987-12-24 2003-04-10 Institut Pasteur Reagent for the detection of Staphylococcus aureus by agglutination
US6680195B1 (en) * 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
WO2007015782A1 (en) * 2005-07-29 2007-02-08 Ecole Polytechnique Federale De Lausanne Molecular variant fibrinogen fusion proteins
WO2010004004A1 (en) * 2008-07-09 2010-01-14 Profibrix Bv Recombinant fibrinogen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FRANCOIS, P. et al., J. Lab Clin. Med., vol. 135, no. 1, pages 32-42 *
VAUDAUX, P. et al., Infection and Immunity, 2002, vol. 70, no. 10, pages 5428-5437 *

Also Published As

Publication number Publication date
KR20130107300A (ko) 2013-10-01
KR101948944B1 (ko) 2019-02-15
US20210148940A1 (en) 2021-05-20
AU2011303467B2 (en) 2016-09-15
US20130164737A1 (en) 2013-06-27
CA2811493A1 (en) 2012-03-22
JP5999776B2 (ja) 2016-09-28
EP3067431A1 (en) 2016-09-14
EP2616550A2 (en) 2013-07-24
WO2012035508A3 (en) 2012-05-18
PT3067431T (pt) 2019-10-29
ES2571127T3 (es) 2016-05-24
WO2012035508A2 (en) 2012-03-22
EP2616550B1 (en) 2016-02-10
CN103108959A (zh) 2013-05-15
HRP20191785T1 (hr) 2019-12-27
HUE028915T2 (en) 2017-01-30
JP2013538355A (ja) 2013-10-10
AU2016266066A1 (en) 2016-12-22
PL2616550T3 (pl) 2016-08-31
SI3067431T1 (sl) 2019-11-29
HK1247280A1 (zh) 2018-09-21
DK3067431T3 (da) 2019-10-14
CN107389932B (zh) 2019-11-22
WO2012035508A4 (en) 2012-07-19
AU2016266066B2 (en) 2017-12-21
EP3067431B1 (en) 2019-07-24
HUE045771T2 (hu) 2020-01-28
US20170336424A1 (en) 2017-11-23
US9689881B2 (en) 2017-06-27
CA2811493C (en) 2020-06-16
CY1122166T1 (el) 2020-11-25
PL3067431T3 (pl) 2019-12-31
DK2616550T3 (en) 2016-05-23
ES2751660T3 (es) 2020-04-01
AU2011303467A1 (en) 2013-04-04
US20240280593A1 (en) 2024-08-22
CN107389932A (zh) 2017-11-24
CN103108959B (zh) 2017-06-09
LT3067431T (lt) 2019-11-11

Similar Documents

Publication Publication Date Title
US20240280593A1 (en) Method for separating target molecules or particles from fibrinogen-containing samples including blood components
US20090269788A1 (en) Method for detecting microorganism
US20190276868A1 (en) Methods for Detecting Microorganisms Using Microorganism Detection Protein and Other Applications of Cell Binding Components
US20200316588A1 (en) Sample collection and processing device
US10281466B2 (en) Method of detecting an analyte using chromatographic enrichment
US10634672B2 (en) Method of detecting a microorganism using chromatographic enrichment
JP2022512167A (ja) 微生物の検出のための自己完結型装置およびシステム
HK1247280B (zh) 用於从含纤维蛋白原的样品中分离目标分子或颗粒的方法
JP2023523627A (ja) メチシリン耐性黄色ブドウ球菌を検出するための組成物、方法およびシステム
EP2682749A1 (en) Method for detecting analyte, and measuring kit
US20240336950A1 (en) Use of a Sustainable, Modified and Enhanced Aquaculture Limulus Amebocyte Lysate Protein for Detection and Characterization of Infectious Pathogens in Biologic Samples for Patient Screening, Diagnosis and Therapeutic Management
Choi Versatile Biological Sample Preparation Platform using Microfluidic Cell Sorting Device
WO2012088412A2 (en) Capture and enrichment of organisms and cells from liquids
Amuso Post protein hydrolysis removal ofa potent ribonuclease inhibitor and the enzymatic capture of

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: DEBIOPHARM INTERNATIONAL SA

Free format text: FORMER APPLICANT(S): SPINOMIX S.A.

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 30 NOV 2016

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 30 NOV 2016

FGA Letters patent sealed or granted (standard patent)